This site is intended for managed care professionals in the U.S.
Professionals in Canada should visit CanadaCGM.com
Source: Diabetes Technology & Therapeutics
Key Takeaway: The present case reports illustrate how telemedicine can be used safely and effectively for new-onset T1D training and education for both pediatric and adult patients and their families. The COVID-19 pandemic has acutely stimulated the expansion of the use of telemedicine and digital medicine. We conclude that telemedicine is an effective approach for the management of patients with new-onset T1D.
This web site is supported by an educational grant from DexCom, Inc.